Visby Medical raises up to $65M to commercialize home STI test

In March, the company received FDA marketing authorization for the first at-home test to detect chlamydia, gonorrhea and trichomoniasis.

Jun 20, 2025 - 20:50
 0
Visby Medical raises up to $65M to commercialize home STI test
In March, the company received FDA marketing authorization for the first at-home test to detect chlamydia, gonorrhea and trichomoniasis.